FdaApplication
NDA 218160
Identifiers
- fda_app_no: NDA218160
Properties
| Property | Value |
|---|---|
| applicant_name | ELI LILLY AND CO |
| application_type | NDA |
| approval_date | 2024-04-10 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RETEVMO | SELPERCATINIB | 80MG | TABLET;ORAL |
| RETEVMO | SELPERCATINIB | 120MG | TABLET;ORAL |
| RETEVMO | SELPERCATINIB | 80MG | CAPSULE;ORAL |
| RETEVMO | SELPERCATINIB | 160MG | TABLET;ORAL |
| RETEVMO | SELPERCATINIB | 40MG | CAPSULE;ORAL |
| RETEVMO | SELPERCATINIB | 40MG | TABLET;ORAL |
6 products